Back to Journals

Pharmacogenomics and Personalized Medicine


Dr Bluth

Department of Pathology, Wayne State University School of Medicine, United States

Dr Bluth

Editor-in-Chief: Dr Martin H. Bluth

Dr. Bluth completed his MD and PhD (Immunology) degrees at SUNY Downstate Medical Center, residency in Clinical Pathology at Kings County Hospital, his fellowship training in Transfusion Medicine at the New York Blood Center and post-doctoral fellowship in tumor markers at the Veteran’s Affairs Medical Center in NY. He maintains board certification in his disciplines. He previously served as Chief Medical Officer for Consolidated Laboratory Management Systems, Vice President for BioMedica Corporation, Director of Research for SUNY Downstate Medical Center among other top tier positions and currently holds an appointment as Professor of Pathology at Wayne State University School of Medicine, Director of Pathology Laboratories for Michigan Surgical Hospital and National Medical Director for Kids Kicking Cancer. He also serves as Associate Editor for Henry’s Clinical Diagnosis and Management by Laboratory Methods, the premier textbook on Clinical Pathology and Laboratory Medicine, as Editor in Chief for four peer reviewed medical journals, and reviews for over a dozen other journals in various disciplines. He is a serial entrepreneur and founder of Bluth Bio Industries, LLC which provides consultation as well as facilitates and matures novel biomarkers, devices and therapeutics (www.bluthbio.com). Dr. Bluth is a leader in laboratory centric drug testing and pharmacovigilance guidance and serves on numerous committees including the Michigan State Medical Society Committee on Health Care Quality, Efficiency and Economics, and consults for numerous healthcare associations and political advocacy entities. Dr. Bluth is considered an expert in his field, has authored over 250 publications, and is sought after for speaking engagements and consultation worldwide. 


Editorial Board

Hiltrud Brauch, Deputy Head, the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.

Carolyn Compton, Professor of Life Sciences; Chief Medical Officer of the Complex Adaptive Systems Initiative, Arizona State University. Professor of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine.

Vicki Ellingrod, Clinical Social and Administrative Sciences, College of Pharmacy and Medicine, University of Michigan, MI, USA

Takahisa Furuta, Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan

Gregory L. Kearns, PharmD, PhD, FCP, FAAP, President, Arkansas Children’s Research Institute; Senior Vice President and Chief Research Officer, Arkansas Children’s; Ross and Mary Whipple Family Distinguished Research Scientist; Professor of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Jing Li, Department of Pharmacology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA

Qing Ma, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, NY, USA

Anke-Hilse Maitland-van der Zee, Professor of Precision Medicine in Respiratory Diseases, Faculty of Medicine, University of Amsterdam, Netherlands.

Gene Morse, Professor, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, NY, USA

Wolfgang Sadee, Felts Mercer Professor of Medicine and Chair; Pharmacology Director, Program in Pharmacogenomics The Ohio State University, USA.

Gaetano Santulli, Research Scholar, Columbia University Medical Center, College of Physicians & Surgeons, New York, NY, USA

Andrew Somogyi, Professor of Clinical and Experimental Pharmacology, Adelaide Medical School, University of Adelaide, Australia.

Michael A. Tainsky, Professor, Department of Oncology, Fred and Barbara Erb Endowed Professor of Cancer Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA

John van den Anker, Professor, Children's National Medical Center, Washington, D.C., USA

Yuan Zhao, Biotherapeutics Group, National Institute for Biological Standards and Control, UK